{"id":1717,"date":"2008-02-01T07:57:39","date_gmt":"2008-02-01T06:57:39","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=1717"},"modified":"2008-02-01T07:57:39","modified_gmt":"2008-02-01T06:57:39","slug":"new-resources-from-hiv-insite-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/1717","title":{"rendered":"New resources from HIV inSite"},"content":{"rendered":"<p><strong>Report on prioritising second-line antiretroviral drugs<\/strong><\/p>\n<p>WHO working group report on prioritising second-line drugs for adults and adolescents. WHO, December 07<\/p>\n<p><a href=\"http:\/\/hivinsite.ucsf.edu\/pdf\/WHO_second_line_ART.pdf\">http:\/\/hivinsite.ucsf.edu\/pdf\/WHO_second_line_ART.pdf<\/a><\/p>\n<p><strong>Missing the target #5: improving AIDS drug access and advancing health care for all<\/strong><\/p>\n<p>The fifth installment of a series on treatment access, this document details country-specific barriers to universal access and provides recommendations for improvement. International Treatment Preparedness Coalition (ITPC). December 2007.<\/p>\n<p>International Treatment Preparedness Coalition (ITPC)<\/p>\n<p><a href=\"http:\/\/www.aidstreatmentaccess.org\">http:\/\/www.aidstreatmentaccess.org<\/a><\/p>\n<p><strong>Epidemiological maps of HIV\/AIDS prevalence and treatment worldwide<\/strong><\/p>\n<p>WHO. 2007.<\/p>\n<p><a href=\"http:\/\/gamapserver.who.int\/mapLibrary\/app\/searchResults.aspx\"><\/a><a href=\"http:\/\/gamapserver.who.int\/mapLibrary\/\">http:\/\/gamapserver.who.int\/mapLibrary<\/a><\/p>\n<p><strong>Updated indicator database for 2007<\/strong><\/p>\n<p>Including revised HIV prevalence and ART coverage estimates from UNAIDS, population statistics from the Population Reference Bureau, and development indicators from UNDP. Using the database, you can easily create a comprehensive report by country, or compare indicators for up to seven countries. Alternatively, pick an indicator and create a report comparing it across 195 countries.<\/p>\n<p><a href=\"http:\/\/hivinsite.ucsf.edu\/global?page=cr-01-00\">http:\/\/hivinsite.ucsf.edu\/global?page=cr-01-00<\/a><\/p>\n<p><strong>New drug profile: raltegravir (Isentress)<\/strong><\/p>\n<p><a href=\"http:\/\/hivinsite.ucsf.edu\/InSite?page=ar-07-01\">http:\/\/hivinsite.ucsf.edu\/InSite?page=ar-07-01<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Report on prioritising second-line antiretroviral drugs WHO working group report on prioritising second-line drugs for adults and adolescents. WHO, December 07 http:\/\/hivinsite.ucsf.edu\/pdf\/WHO_second_line_ART.pdf Missing the target #5: improving AIDS drug access and advancing health care for all The fifth installment of &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-1717","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/1717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=1717"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/1717\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=1717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=1717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=1717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}